GlassScriptPhysician profile
Jianguo Cheng
NPI 1619967973
$23,048.53
in general payments reported to CMS, 2019-2025
22 companies · $9,251 in 2025
The $9,251 reported for 2025 was more than what 95% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $698 · 2020: $434 · 2021: $4,619 · 2022: $532 · 2023: $7,104 · 2024: $410 · 2025: $9,251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $10K · Travel and Lodging: $3,737 · Food and Beverage: $2,634.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $10,395.00 |
| Travel and Lodging | $3,737.32 |
| Food and Beverage | $2,633.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $12,620.88 | 2021-2025 | |
| Averitas Pharma INC. | $5,609.48 | 2023 | Qutenza |
| Saluda Medical Americas, INC. | $1,464.30 | 2022-2023 | Evoke Scs |
| Nevro Corp. | $936.13 | 2019-2024 | Senza |
| Globus Medical, INC. | $607.33 | 2022-2025 | Senza |
| Mml US, INC. | $359.18 | 2021 | |
| Medtronic USA, INC. | $264.86 | 2019-2020 | |
| Stimwave Technologies Incorporated | $180.43 | 2019 | |
| Grt US Holding, INC. | $135.98 | 2022 | |
| Abbott Laboratories | $135.15 | 2024 | Proclaim |
| Boston Scientific Corporation | $110.12 | 2025 | General - Pain Management |
| Relievant Medsystems, INC. | $107.74 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $101.67 | 2019 | |
| Vertos Medical, INC. | $100.74 | 2024 | Mild Device Kit |
| Spr Therapeutics, INC | $79.79 | 2019-2021 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tonix Medicines, INC. | $77.10 | 2025 | |
| Heron Therapeutics, INC. | $69.07 | 2021 | |
| Biodelivery Sciences International, INC. | $29.48 | 2019 | |
| Noven Therapeutics, LLC | $20.04 | 2022 | |
| Alkermes, INC. | $13.60 | 2022 | |
| Siemens Medical Solutions USA, INC. | $13.38 | 2023 | Cios Flow |
| Almatica Pharma LLC | $12.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jianguo Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.